Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.

Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.

Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.

Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.

Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.

Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.

Abstract: Systems, methods and articles that provide dynamic calibration of eye tracking systems for wearable heads-up displays (WHUDs). The eye tracking system may determine a user's gaze location on a display of the WHUD utilizing a calibration point model that includes a plurality of calibration points. During regular use of the WHUD by the user, the calibration point model may be dynamically updated based on the user's interaction with user interface (UI) elements presented on the display. The UI elements may be specifically designed (e.g., shaped, positioned, displaced) to provide in-use and on-going dynamic calibration of the eye tracking system, which in at least some implementations may be unnoticeable to the user.

Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.

Abstract: The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.

Abstract: The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.

Abstract: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.